SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD.

Consensus Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

Equities

688266

CNE100003RP1

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
56.32 ^CNY	+5.73%		+1.84%	+6.38%

Apr. 19	Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 12	Suzhou Zejing Topical Vitiligo Cream Gets NMPA's Nod for Clinical Trials	MT

Evolution of the average Target Price on Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

Price target over the last 5 years

History of analyst recommendation changes

961ea621c87511fa39942bd6b0954f3.3mlHVbXVaeTDvBnAHXUapleLndmzpUyK447TcRhtbNE.ugoqJIe7KqqohFyULyx73y7_8bPWnCW-lcjqFEEjBuGEWzE3g5otvrOJcg~a836d011c9b0501f5086d9572e932489

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

56.32 CNY

Average target price

64 CNY

Spread / Average Target

+13.64%

High Price Target

64 CNY

Spread / Highest target

+13.64%

Low Price Target

64 CNY

Spread / Lowest Target

+13.64%

Consensus detail

Consensus revision (last 18 months)

Ratings for Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar